A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV C.
Env-specific IgG and IgM were detected in 25 and 60%, respectively, of volunteers immunized with NYVAC expressing clade C gp120. The serum sample with the highest IgM titre but undetectable IgG neutralized the homologous isolate with a reciprocal IC90 titre of 7.8 in the absence of complement, and 2...
主要な著者: | Sheppard, N, Bates, A, Sattentau, Q |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses
著者:: Beatriz Perdiguero, 等
出版事項: (2019-12-01) -
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
著者:: Bart, P, 等
出版事項: (2008) -
HIV Env induces the formation of supramolecular activation structures in CD4+ T cells
著者:: Jolly, C, 等
出版事項: (2002) -
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
著者:: Beatriz Perdiguero, 等
出版事項: (2022-07-01) -
rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
著者:: Montefiori DC, 等
出版事項: (2012-09-01)